Nephrotic syndrome is associated with increased plasma K+ concentration, intestinal K+ losses, and attenuated urinary K+ excretion: a study in rats and humans

Am J Physiol Renal Physiol. 2019 Dec 1;317(6):F1549-F1562. doi: 10.1152/ajprenal.00179.2019. Epub 2019 Sep 30.

Abstract

The present study tested the hypotheses that nephrotic syndrome (NS) leads to renal K+ loss because of augmented epithelial Na+ channel (ENaC) activity followed by downregulation of renal K+ secretory pathways by suppressed aldosterone. The hypotheses were addressed by determining K+ balance and kidney abundance of K+ and Na+ transporter proteins in puromycin aminonucleoside (PAN)-induced rat nephrosis. The effects of amiloride and angiotensin II type 1 receptor and mineralocorticoid receptor (MR) antagonists were tested. Glucocorticoid-dependent MR activation was tested by suppression of endogenous glucocorticoid with dexamethasone. Urine and plasma samples were obtained from pediatric patients with NS in acute and remission phases. PAN-induced nephrotic rats had ENaC-dependent Na+ retention and displayed lower renal K+ excretion but elevated intestinal K+ secretion that resulted in less cumulated K+ in NS. Aldosterone was suppressed at day 8. The NS-associated changes in intestinal, but not renal, K+ handling responded to suppression of corticosterone, whereas angiotensin II type 1 receptor and MR blockers and amiloride had no effect on urine K+ excretion during NS. In PAN-induced nephrosis, kidney protein abundance of the renal outer medullary K+ channel and γ-ENaC were unchanged, whereas the Na+-Cl- cotransporter was suppressed and Na+-K+-ATPase increased. Pediatric patients with acute NS displayed suppressed urine Na+-to-K+ ratios compared with remission and elevated plasma K+ concentration, whereas fractional K+ excretion did not differ. Acute NS is associated with less cumulated K+ in a rat model, whereas patients with acute NS have elevated plasma K+ and normal renal fractional K+ excretion. In NS rats, K+ balance is not coupled to ENaC activity but results from opposite changes in renal and fecal K+ excretion with a contribution from corticosteroid MR-driven colonic secretion.

Keywords: channel; colon; edema; hypertension; potassium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aldosterone / metabolism
  • Amiloride / pharmacology
  • Angiotensin II Type 2 Receptor Blockers / pharmacology
  • Animals
  • Child
  • Child, Preschool
  • Diuretics
  • Down-Regulation
  • Epithelial Sodium Channels / metabolism
  • Humans
  • Infant
  • Kidney / drug effects
  • Kidney / metabolism
  • Male
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Nephrotic Syndrome / blood
  • Nephrotic Syndrome / metabolism*
  • Nephrotic Syndrome / urine
  • Potassium / blood
  • Potassium / metabolism*
  • Potassium / urine
  • Potassium Channels / metabolism
  • Puromycin Aminonucleoside
  • Rats
  • Rats, Sprague-Dawley
  • Sodium-Potassium-Exchanging ATPase / metabolism

Substances

  • Angiotensin II Type 2 Receptor Blockers
  • Diuretics
  • Epithelial Sodium Channels
  • Mineralocorticoid Receptor Antagonists
  • Potassium Channels
  • Aldosterone
  • Puromycin Aminonucleoside
  • Amiloride
  • Sodium-Potassium-Exchanging ATPase
  • Potassium